Showing results (211-220 of 1,557) with videos related to

Sort By:
Pageof 156
Inflammatory Bowel Diseases|October 16, 2010
Optimizing thiopurine therapy in inflammatory bowel diseaseJean-Baptiste Chevaux, Laurent Peyrin-Biroulet, Miles P Sparrow
Current Drug Targets|September 9, 2014
Catching the therapeutic window of opportunity in early Crohn's diseaseSilvio Danese, Gionata Fiorino, Carlos Fernandes, et al.
World Journal of Gastroenterology|April 4, 2014
Microscopic features of colorectal neoplasia in inflammatory bowel diseasesAude Bressenot, Virginie Cahn, Silvio Danese, et al.
Current Pharmaceutical Design|March 9, 2019
Anti-adhesion Molecules in IBD: Does Gut Selectivity Really Make the Difference?Ferdinando D'Amico, Giulia Roda, Laurent Peyrin-Biroulet, et al.
Expert Review of Gastroenterology & Hepatology|March 23, 2023
A critical review of ustekinumab for the treatment of active ulcerative colitis in adultsSophie Vieujean, Edouard Louis, Silvio Danese, et al.
Med (New York, N.Y.)|December 13, 2025
TL1A blockade in inflammatory bowel diseases: Clinical trials to watchFerdinando D'Amico, Laurent Peyrin-Biroulet, Vipul Jairath, et al.
European Journal of Applied Physiology and Occupational Physiology|January 10, 1979
[Adrenergic response to intense muscular activity in sedentary subjects as a function of emotivity and training]J M Pequignot, L Peyrin, R Favier, et al.
Journal of Crohn'S & Colitis|January 9, 2016
Preventing Collateral Damage in Crohn's Disease: The Lémann IndexGionata Fiorino, Cristiana Bonifacio, Laurent Peyrin-Biroulet, et al.
Analytical Chemistry|July 28, 2009
Determination of cocaine in human plasma by selective solid-phase extraction using an aptamer-based sorbentBenjamin Madru, Florence Chapuis-Hugon, Eric Peyrin, et al.
Sensors (Basel, Switzerland)|March 30, 2023
Original and Low-Cost ADS-B System to Fulfill Air Traffic Safety Obligations during High Power LIDAR OperationFrédéric Peyrin, Patrick Fréville, Nadège Montoux, et al.
Pageof 156